PRACTICAL ISSUES OF CYCLOSPORINE IN THE TREATMENT OF GLOMERULOPATHY
https://doi.org/10.24884/1561-6274-2010-14-4-96-102
Abstract
Based on current concepts of mechanisms of action of cyclosporine the practical recommendations on its application in various forms of idiopathic glomerulopathies are provided.
About the Authors
A. V. Smirnov
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Russian Federation
Russian Federation
I. I. Trofimenko
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Russian Federation
Russian Federation
References
1. Смирнов АВ. Лечение гломерулопатий циклоспорином. Правильный подход с неверным обоснованием. Нефрология 2010; 14 (4): 9-22
2. Alexopoulos E, Papagianni A, Tsamelashvili M et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006; 21 (11): 3127-3132
3. Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007; 72 (12): 1429-1447
4. Goumenos DS, Katopodis KP, Passadakis P et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol 2007; 27 (3): 226-231
5. Ehrich JH, Geerlings C, Zivicnjak M et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22 (8): 2183-2193
6. Goumenos DS. What have we learned from the use of cyclosporine A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert Opin Pharmacother 2008; 9(10): 1695-1704
7. Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16 (3): CD003233
8. Захарова ЕВ, Бирюкова ЛС. Роль циклоспорина в лечении идиопатического гломерулонефрита и волчаночного нефрита. Нефрология и диализ 2010; 12(2): 126-141
9. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose, Shannon MW, Borron SW, Burns MJ 4th ed., 2007; Saunders,1584
10. Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112(1): 184-198
11. Robert N, Wong GWK, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007893
12. Kelley’s Textbook of Rheumatology, Ed. Firestein GS, Budd RC, Harris ED,et al. 8th ed., Saunders, 2064
13. Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant 2006; 21(8): 2060-2063
14. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4(2): 481-508
15. Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007; 67(6): 335-340
16. Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 2009; 24(2): 81-92
17. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56 (6): 2220-2226
18. Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20(3): 268-287
Review
For citations:
Smirnov A.V., Trofimenko I.I. PRACTICAL ISSUES OF CYCLOSPORINE IN THE TREATMENT OF GLOMERULOPATHY. Nephrology (Saint-Petersburg). 2010;14(4):96-102. (In Russ.) https://doi.org/10.24884/1561-6274-2010-14-4-96-102
Views:
335
Email this article 